{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T17:45:47Z","timestamp":1772991947226,"version":"3.50.1"},"reference-count":17,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:00:00Z","timestamp":1515110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology International"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:sec><jats:label\/><jats:p>Malignant mesothelioma (MM) with rhabdoid features is an MM variant. Fifteen cases have been reported previously, all of which were combined with other types of MM. Herein, we report an autopsy case of pleural MM with monomorphic rhabdoid features. The patient was a 62\u2010year\u2010old male without a history of asbestos exposure. An autopsy revealed a soft, granular tumor that replaced the entire left pleura and had invaded to the diaphragm and lower lobe of the lung. The tumor cells, which had eosinophilic plump cytoplasm and eccentric nuclei, were loosely cohesive. Immunohistochemistry showed that the cells were diffusely positive for calretinin, D2\u201040, vimentin, CAM5.2, and AE1\/AE3; and negative for WT\u20101, TTF\u20101, CK7, CEA, desmin, CD34, BCL\u20102, S100 protein, and p40. Neither homozygous deletion of <jats:italic>p16<\/jats:italic> nor BAP\u20101 protein loss was observed. Loss of INI1\/BAF47 protein, an indicator of malignant rhabdoid tumor, was observed. Therefore, MM with rhabdoid features was confirmed.<\/jats:p><\/jats:sec>","DOI":"10.1111\/pin.12623","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T02:54:55Z","timestamp":1515552895000},"page":"128-132","source":"Crossref","is-referenced-by-count":11,"title":["SMARCB1\/INI1\/BAF47\u2010 deficient pleural malignant mesothelioma with rhabdoid features"],"prefix":"10.1111","volume":"68","author":[{"given":"Noriko","family":"Kimura","sequence":"first","affiliation":[{"name":"Department of Diagnostic Pathology, and Department of Clinical Research Pathology Division"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine National Hospital Organization Hakodate Hospital Hakodate"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Hiroshima","sequence":"additional","affiliation":[{"name":"Department of Pathology (KH) Tokyo Women's Medical University Yachiyo Medical Center Yachiyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"154","volume-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart","author":"Galateau\u2010Salle F","year":"2015"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800543"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1996.tb03627.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00713281"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(81)80050-0"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820601)49:11<2365::AID-CNCR2820491125>3.0.CO;2-I"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2006.01962.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0214-OA"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPT94JVWIHBKRD"},{"key":"e_1_2_6_11_1","first-page":"559","article-title":"Expression of thrombomodulin, calretinin, cytokeratin 5\/6, D2\u201040 and WT\u20101 in a series of primary carcinomas of the lung: An immunohistochemical study in comparison with epithelioid pleural mesothelioma","volume":"100","author":"Comin CE","year":"2014","journal-title":"Tumori"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.4081\/pr.2015.5578"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.8.5.8019"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2016.04.018"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2017.05.024"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.61"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid\u2010type malignant mesothelioma","volume":"2103","author":"Yoshikawa Y","year":"2012","journal-title":"Cancer Sci"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2015.06.024"}],"container-title":["Pathology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpin.12623","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pin.12623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T10:32:28Z","timestamp":1695724348000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pin.12623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1111\/pin.12623"],"URL":"https:\/\/doi.org\/10.1111\/pin.12623","archive":["Portico"],"relation":{},"ISSN":["1320-5463","1440-1827"],"issn-type":[{"value":"1320-5463","type":"print"},{"value":"1440-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,5]]}}}